Skip to main content
SRTS
NASDAQ Industrial Applications And Services

Sensus Healthcare Reports 59% Q1 Revenue Drop, Credit Facility Terminated

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$3.485
Mkt Cap
$57.37M
52W Low
$2.82
52W High
$5.92
Market data snapshot near publication time

summarizeSummary

Sensus Healthcare reported a 59% year-over-year revenue decline and increased net loss for Q1 2026, compounded by the upcoming termination of its $15 million credit facility, raising significant liquidity concerns.


check_boxKey Events

  • Revenue Plummets 59%

    Q1 2026 revenue decreased by 59% year-over-year to $3.4 million, primarily due to lower unit sales and a shift to Fair Deal Agreement and rental programs where revenue is recognized over time.

  • Credit Facility Terminated

    The company's $15 million revolving credit facility will terminate on May 20, 2026, following a default on profitability covenants. This significantly impacts liquidity and future funding options.

  • Increased Net Loss and Reduced Gross Margin

    Net loss for Q1 2026 increased slightly to $2.6 million, and the gross profit margin sharply declined from 53.0% in Q1 2025 to 29.4% in Q1 2026, reflecting product mix changes and upfront costs for new programs.

  • Cash Reserves Decline

    Cash and cash equivalents decreased by $3.8 million in the quarter, from $22.1 million at December 31, 2025, to $18.3 million at March 31, 2026.


auto_awesomeAnalysis

Sensus Healthcare's Q1 2026 results show a significant deterioration in financial performance, with revenue plummeting 59% year-over-year to $3.4 million and an increased net loss of $2.6 million. This follows the 8-K filed on May 7, 2026, which initially reported the revenue decline. Critically, the company disclosed that its $15 million revolving credit facility, which it was already in default on due to profitability covenants, will terminate on May 20, 2026. This termination, coming after a 2025 net loss of $7.7 million reported in the March 4, 2026 10-K, severely impacts the company's liquidity and ability to access capital, despite management's assertion of sufficient funds for the next 12 months. The substantial decline in gross profit margin from 53.0% to 29.4% further highlights operational challenges.

At the time of this filing, SRTS was trading at $3.49 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $57.4M. The 52-week trading range was $2.82 to $5.92. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SRTS - Latest Insights

SRTS
May 13, 2026, 2:48 PM EDT
Filing Type: 10-Q
Importance Score:
9
SRTS
May 08, 2026, 1:55 PM EDT
Source: Reuters
Importance Score:
7
SRTS
May 07, 2026, 4:31 PM EDT
Source: Reuters
Importance Score:
9
SRTS
May 07, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
SRTS
Mar 27, 2026, 8:05 AM EDT
Source: Reuters
Importance Score:
8
SRTS
Mar 04, 2026, 12:15 PM EST
Filing Type: 10-K
Importance Score:
9
SRTS
Feb 12, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
8
SRTS
Jan 09, 2026, 7:25 PM EST
Filing Type: 8-K
Importance Score:
7